Hoffmann-La Roche
4 registered trials on this site, 4 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes NCT07351045 | Enicepatide (CT-388) | Phase 3 | Recruiting | Hoffmann-La Roche | 2,000 | Jul 24, 2028 | Sep 14, 2026 |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes NCT07351058 | Enicepatide (CT-388) | Phase 3 | Recruiting | Hoffmann-La Roche | 1,600 | Aug 7, 2028 | Sep 14, 2026 |
| A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes NCT07670416 | Enicepatide (CT-388) | Phase 3 | Recruiting | Hoffmann-La Roche | 300 | Feb 24, 2028 | Sep 10, 2026 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants NCT07626515 | Enicepatide (CT-388) | Phase 1 | Recruiting | Hoffmann-La Roche | 36 | May 14, 2027 | Sep 8, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
